These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 2521507

  • 1. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.
    Hirsch R, Gress RE, Pluznik DH, Eckhaus M, Bluestone JA.
    J Immunol; 1989 Feb 01; 142(3):737-43. PubMed ID: 2521507
    [Abstract] [Full Text] [Related]

  • 2. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
    Hirsch R, Archibald J, Gress RE.
    J Immunol; 1991 Oct 01; 147(7):2088-93. PubMed ID: 1833451
    [Abstract] [Full Text] [Related]

  • 3. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA, June CH, Martin PJ, Spooner CE, Hansen JA, Meier KE.
    J Immunol; 1986 Jun 01; 136(11):3945-52. PubMed ID: 3084650
    [Abstract] [Full Text] [Related]

  • 4. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.
    Blazar BR, Hirsch R, Gress RE, Carroll SF, Vallera DA.
    J Immunol; 1991 Sep 01; 147(5):1492-503. PubMed ID: 1831826
    [Abstract] [Full Text] [Related]

  • 5. Contrasting in vivo effects on T helper cell functions induced by mitogenic (intact) versus nonmitogenic (F(ab')2) anti-CD3 monoclonal antibody.
    Sawchuk SS, Gates R, Hirsch R.
    Transplantation; 1995 Dec 15; 60(11):1331-7. PubMed ID: 8525530
    [Abstract] [Full Text] [Related]

  • 6. Direct activation of murine resting T cells by con A or anti-CD3 Ig.
    Quintáns J, Yokoyama A, Evavold B, Hirsch R, Mayforth RD.
    J Mol Cell Immunol; 1989 Dec 15; 4(4):225-35; discussion 235-7. PubMed ID: 2532886
    [Abstract] [Full Text] [Related]

  • 7. Induction of immune tolerance during administration of monoclonal antibody to L3T4 does not depend on depletion of L3T4+ cells.
    Carteron NL, Wofsy D, Seaman WE.
    J Immunol; 1988 Feb 01; 140(3):713-6. PubMed ID: 2448372
    [Abstract] [Full Text] [Related]

  • 8. Cell surface comodulation of CD4 and T cell receptor by anti-CD4 monoclonal antibody.
    Cole JA, McCarthy SA, Rees MA, Sharrow SO, Singer A.
    J Immunol; 1989 Jul 15; 143(2):397-402. PubMed ID: 2786906
    [Abstract] [Full Text] [Related]

  • 9. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M, Guy R, Waldmann H, Glennie M, Alexander DR.
    Cell Immunol; 1998 May 01; 185(2):101-13. PubMed ID: 9636688
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation.
    Portoles P, Rojo J, Golby A, Bonneville M, Gromkowski S, Greenbaum L, Janeway CA, Murphy DB, Bottomly K.
    J Immunol; 1989 Jun 15; 142(12):4169-75. PubMed ID: 2470817
    [Abstract] [Full Text] [Related]

  • 11. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
    Blazar BR, Taylor PA, Vallera DA.
    J Immunol; 1994 Apr 01; 152(7):3665-74. PubMed ID: 8144942
    [Abstract] [Full Text] [Related]

  • 12. Stimulation of murine T cell subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules.
    Ernst DN, Weigle WO, McQuitty DN, Rothermel AL, Hobbs MV.
    J Immunol; 1989 Mar 01; 142(5):1413-21. PubMed ID: 2521878
    [Abstract] [Full Text] [Related]

  • 13. Down-regulation of IL-2 production by activation of T cells through Ly-6A/E.
    Codias EK, Rutter JE, Fleming TJ, Malek TR.
    J Immunol; 1990 Sep 01; 145(5):1407-14. PubMed ID: 2143518
    [Abstract] [Full Text] [Related]

  • 14. CD44 contributes to T cell activation.
    Huet S, Groux H, Caillou B, Valentin H, Prieur AM, Bernard A.
    J Immunol; 1989 Aug 01; 143(3):798-801. PubMed ID: 2568380
    [Abstract] [Full Text] [Related]

  • 15. Treatment of murine lupus with F(ab')2 fragments of monoclonal antibody to L3T4. Suppression of autoimmunity does not depend on T helper cell depletion.
    Carteron NL, Schimenti CL, Wofsy D.
    J Immunol; 1989 Mar 01; 142(5):1470-5. PubMed ID: 2521880
    [Abstract] [Full Text] [Related]

  • 16. Activation of T cells by cross-linking an anti-CD3 antibody with a second anti-T cell antibody: mechanism and subset-specific activation.
    Walker C, Bettens F, Pichler WJ.
    Eur J Immunol; 1987 Jun 01; 17(6):873-80. PubMed ID: 2439351
    [Abstract] [Full Text] [Related]

  • 17. Anti-CD3 epsilon F(ab')2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen.
    Blazar BR, Jenkins MK, Taylor PA, White J, Panoskaltsis-Mortari A, Korngold R, Vallera DA.
    J Immunol; 1997 Dec 15; 159(12):5821-33. PubMed ID: 9550378
    [Abstract] [Full Text] [Related]

  • 18. Proliferative capacity of senescent lymphocytes. II. Monoclonal antibody stimulation of mucosal and systemic lymphocytes via T cell activation molecules, CD3 epsilon, T cell receptor V beta 8 chain, and phosphatidylinositol-linked anchored receptors THY-1 and LY-6A.2/TAP.
    Green-Johnson JM, Szewczuk MR.
    Reg Immunol; 1997 Dec 15; 3(6):323-35. PubMed ID: 1983438
    [Abstract] [Full Text] [Related]

  • 19. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK, Doyle LV.
    J Immunol; 1989 Sep 15; 143(6):1761-7. PubMed ID: 2570801
    [Abstract] [Full Text] [Related]

  • 20. In vivo immunosuppression induced by a weakly mitogenic antibody to mouse CD3: evidence that induction of long-lasting in vivo unresponsiveness requires TcR signaling.
    Flamand V, Donckier V, Abramowicz D, Goldman M, Vandenabeele P, Urbain J, Moser M, Leo O.
    Cell Immunol; 1994 Aug 15; 157(1):239-48. PubMed ID: 8039247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.